Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Non-Prescription Drugs

          

Consumer Self-Care Americas (Csca)

2.69B 2.93B 2.96B 2.69B 2.59B

Total Assets

5.98B 5.13B 4.95B 4.69B 3.49B

CAPEX

-112M -68.1M -66.4M -84.5M -58M

Gross Profit

765M 787M 908M 779M 755M

D&A

117M 123M 133M 138M 154M

Operating Income

206M 366M 390M 270M -669M

Consumer Self-Care International(Csci)

1.45B 1.53B 1.69B 1.68B 1.67B

Total Assets

4.43B 5.88B 5.86B 4.96B 5.04B

CAPEX

-24M -26.2M -35.3M -33.8M -35.4M

Gross Profit

651M 668M 772M 764M 740M

D&A

180M 215M 226M 188M 184M

Operating Income

36.1M -30M -35.2M 105M -229M

Dental Care Products

          

All Other

- - - - -

Total Assets

- - - - -

CAPEX

- - - - -

Gross Profit

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Pharmaceutical Products

          

Prescription Pharmaceuticals (rx)

- - - - -

Total Assets

- - - - -

CAPEX

- - - - -

Gross Profit

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Total Assets

- - - - -

Operating Income

- - - - -

Total Assets

16.1M - - - -

Operating Income

168M -257M -202M -262M -224M

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

United States (U.S.)

2.57B 2.87B 2.92B 2.65B 2.54B

Total Assets

675M 725M 720M 720M 674M

Total Assets

- - - - -

Europe (Excl. Ireland)

1.37B 1.44B 1.58B 1.56B 1.57B

Total Assets

174M 188M 185M 196M 221M

All Other Countries

180M 107M 116M 120M 96.7M

Total Assets

14.8M 12.7M 11.5M 100K 200K

Ireland

23.7M 29.3M 40.8M 39.6M 42.1M

Total Assets

100K - 200K 1.7M 3.5M
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW